Literature DB >> 14960539

The diagnostic dilemmas in discrimination between pancreatic carcinoma and chronic pancreatitis.

A Harlozinska-Szmyrka, M Strutynska-Karpinska.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14960539      PMCID： PMC1773962     

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  9 in total

1.  Tissue polypeptide specific antigen (TPS), a marker for differentiation between pancreatic carcinoma and chronic pancreatitis. A comparative study with CA 19-9.

Authors:  B Slesak; A Harlozinska-Szmyrka; W Knast; P Sedlaczek; A van Dalen; R Einarsson
Journal:  Cancer       Date:  2000-07-01       Impact factor: 6.860

2.  Serum CA 242: the search for a valid marker of pancreatic cancer.

Authors:  M Ventrucci; G M Ubalducci; A Cipolla; M A Panella; A Ligabue
Journal:  Clin Chem Lab Med       Date:  1998-03       Impact factor: 3.694

3.  Molecular characterization of a tissue-polypeptide-specific-antigen epitope and its relationship to human cytokeratin 18.

Authors:  L Rydlander; E Ziegler; T Bergman; E Schöberl; G Steiner; A C Bergman; A Zetterberg; M Marberger; P Björklund; T Skern; R Einarsson; H Jörnvall
Journal:  Eur J Biochem       Date:  1996-10-15

4.  Risk of pancreatic adenocarcinoma in chronic pancreatitis.

Authors:  D Malka; P Hammel; F Maire; P Rufat; I Madeira; F Pessione; P Lévy; P Ruszniewski
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

5.  Serum tumor markers and cyst fluid analysis are useful for the diagnosis of pancreatic cystic tumors.

Authors:  C Sperti; C Pasquali; P Guolo; R Polverosi; G Liessi; S Pedrazzoli
Journal:  Cancer       Date:  1996-07-15       Impact factor: 6.860

6.  CAM 17.1--a new diagnostic marker in pancreatic cancer.

Authors:  F Gansauge; S Gansauge; N Parker; M I Beger; B Poch; K H Link; F Safi; H G Beger
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

7.  Behavior of tumor markers CA19.9, CA195, CAM43, CA242, and TPS in the diagnosis and follow-up of pancreatic cancer.

Authors:  G Banfi; A Zerbi; S Pastori; D Parolini; V Di Carlo; P Bonini
Journal:  Clin Chem       Date:  1993-03       Impact factor: 8.327

8.  Diagnostic value of tissue polypeptide specific antigen in patients with pancreatic carcinoma.

Authors:  P A Pasanen; M Eskelinen; K Partanen; P Pikkarainen; I Penttilä; E Alhava
Journal:  Tumour Biol       Date:  1994

9.  Comparative study of CA242 and CA19-9 for the diagnosis of pancreatic cancer.

Authors:  S Kawa; M Tokoo; O Hasebe; K Hayashi; H Imai; H Oguchi; K Kiyosawa; S Furuta; T Homma
Journal:  Br J Cancer       Date:  1994-09       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.